<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04896151</url>
  </required_header>
  <id_info>
    <org_study_id>2020B0414</org_study_id>
    <nct_id>NCT04896151</nct_id>
  </id_info>
  <brief_title>Assessing the Utility of MMPI-2-RF-EX in Detecting Simulated Underreporting of Current Suicide Risk in Military Veterans</brief_title>
  <official_title>Assessing the Utility of MMPI-2-RF-EX in Detecting Simulated Underreporting of Current Suicide Risk in Military Veterans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ohio State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Minnesota</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rutgers University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ohio State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the current project are is examine the incremental predictive utility of the&#xD;
      MMPI-2-RF-EX validity scales in detecting simulated underreporting of suicide risk on the&#xD;
      MMPI-2-RF-EX and other self-report measures of suicide risk in 150 military Veterans&#xD;
      experiencing past-month death or suicidal ideation.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 15, 2021</start_date>
  <completion_date type="Anticipated">May 15, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 15, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>MMPI-2-RF-EX Suicidal/Death Ideation scale</measure>
    <time_frame>Baseline</time_frame>
    <description>The MMPI-2-RF-EX Suicidal/Death Ideation scale is a self-report measure of current suicide risk contained within the instrument. T scores range from 45 to 100, with higher scores indicative of greater suicide risk.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Beck Scale for Suicide Ideation (BSS)</measure>
    <time_frame>Baseline</time_frame>
    <description>The BSS is a 21-item measure of past-week suicide ideation and desire for death. Responses to items are scored on a 3-point Likert scale (range of 0- 2). Scores range from 0 to 42, with higher scores indicating greater suicide risk.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Suicide Cognitions Scale (SCS)</measure>
    <time_frame>Baseline</time_frame>
    <description>The SCS is an 18-item survey measuring suicide-related thoughts and beliefs, unclouding hopelessness, perceived burdensomeness, entrapment, and unbearability. Respondents rate their agreement with each statement on a 5-point Likert scale. Scores range from 18-90, with higher scores indicating more severe suicide risk.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Short Grit Scale</measure>
    <time_frame>Baseline</time_frame>
    <description>The Short Grit Scale is an 8-item measure of trait-level perseverance and passion for long-term goals. Possible scores range from 5 to 40, with higher scores indicting higher levels of grit.</description>
  </other_outcome>
  <other_outcome>
    <measure>MMPI Posttest Inquiry (PTI)</measure>
    <time_frame>Baseline</time_frame>
    <description>The PTI assesses participants' compliance with condition-specific instructions for completing the MMPI and was adapted for the proposed research</description>
  </other_outcome>
  <other_outcome>
    <measure>PTSD Checklist for DSM-5 (PCL-5) PTSD Checklist for DSM-5</measure>
    <time_frame>Baseline</time_frame>
    <description>The PCL-5 is a self-report measure assessing the severity of 20 PTSD symptoms. Scores range from 0 to 80, with higher scores indicating greater PTSD symptom severity.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Suicidal Ideation</condition>
  <condition>Suicidal</condition>
  <arm_group>
    <arm_group_label>Standard MMPI</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will be instructed to complete the MMPI-2-RF-EX and other measures under standard conditions (e.g., to not simulate underreporting of suicide risk).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Simulation MMPI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will be instructed to conceal current suicide risk when completing the MMPI-2-RF-EX and other measures.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Minnesota Multiphasic Personality Inventory -2- Restructured Form - Experimental</intervention_name>
    <description>The MMPI-2-RF-EX is a broadband, self-report measure of personality and psychopathology was developed for research purposes in order to develop the MMPI-3 (Ben-Porath &amp; Tellegen, 2020), which is comprised of a subset of MMPI-2-RF-EX items.</description>
    <arm_group_label>Simulation MMPI</arm_group_label>
    <arm_group_label>Standard MMPI</arm_group_label>
    <other_name>MMPI-2-RF-EX</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years of age or older&#xD;
&#xD;
          -  US military veteran&#xD;
&#xD;
          -  death or suicidal ideation/suicide attempt within the past month&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  non-Veteran status&#xD;
&#xD;
          -  acute intoxication or active psychosis precluding provision of informed consent&#xD;
&#xD;
          -  an inability to communicate and comprehend English&#xD;
&#xD;
          -  residence outside the United States&#xD;
&#xD;
          -  lack of past-month death/suicide ideation or attempt&#xD;
&#xD;
          -  younger than 18 years of age&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lauren Khazem, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Ohio State University Wexner Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lauren Khazem, PhD</last_name>
    <phone>(614) 293-9600</phone>
    <email>lauren.khazem@osumc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Craig Bryan, PsyD</last_name>
    <phone>614--366-2314</phone>
    <email>craig.bryan@osumc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43214</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>lauren R Khazem, PhD</last_name>
      <phone>614-366-2314</phone>
      <email>lauren.khazem@osumc.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>May 1, 2021</study_first_submitted>
  <study_first_submitted_qc>May 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 21, 2021</study_first_posted>
  <last_update_submitted>July 6, 2021</last_update_submitted>
  <last_update_submitted_qc>July 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ohio State University</investigator_affiliation>
    <investigator_full_name>Lauren Khazem</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Suicide</mesh_term>
    <mesh_term>Suicidal Ideation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>February 25, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/51/NCT04896151/Prot_SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>February 25, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/51/NCT04896151/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

